Site icon OncologyTube

GRACE Targeted Therapies Lung Cancer 2021 – Best Treatment Patient with a Designated KRAS Mutation

The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.

In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss how a patient with a designated KRAS mutation ensures the best treatment.

A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Exit mobile version